MoonLake Immunotherapeutics MLTX Total Non-Current Liabilities
Total Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's total non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's total non-current liabilities?
- MoonLake Immunotherapeutics (MLTX) reported total non-current liabilities of $100.24M in Q1 2026.
- How has MoonLake Immunotherapeutics's total non-current liabilities changed year-over-year?
- MoonLake Immunotherapeutics's total non-current liabilities increased by 34.2% year-over-year, from $74.7M to $100.24M.
- What is the long-term trend for MoonLake Immunotherapeutics's total non-current liabilities?
- Over 4 years (2021 to 2025), MoonLake Immunotherapeutics's total non-current liabilities has grown at a 319.8% compound annual growth rate (CAGR), from $239.86K to $74.47M.
- What does total non-current liabilities mean?
- The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.